Biohaven Ownership | Who Owns Biohaven?

Biohaven Ownership Summary

Biohaven is owned by 22.82% institutional investors, 11.08% insiders, and 66.10% retail investors. Janus henderson group is the largest institutional shareholder, holding 14.59% of BHVN shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.82% of its assets in Biohaven shares.

BHVN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Biohaven	22.82%	11.08%	66.10%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	17.53M	14.59%	$148.21M
Blackrock funding, inc. /de	11.22M	9.34%	$94.94M
Suvretta capital management	10.29M	8.56%	$87.03M
Stifel financial	9.94M	8.27%	$84.10M
Blackrock	6.17M	7.56%	$214.15M
State street	6.62M	5.51%	$56.00M
Infinitum asset management	6.25M	5.20%	$52.88M
Vanguard group	4.40M	4.15%	$49.63M
Tcg crossover management	4.63M	3.85%	$39.18M
Rp management	2.94M	3.11%	$146.74M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rp management	2.94M	64.43%	$146.74M
Infinitum asset management	6.25M	6.60%	$52.88M
Oracle investment management	673.17K	6.51%	$9.50M
Sarissa capital management lp	563.18K	3.02%	$4.76M
Bison wealth	332.43K	2.74%	$12.42M
Stempoint capital lp	1.59M	2.62%	$13.49M
Lion point capital, lp	51.70K	2.61%	$437.38K
Suvretta capital management	10.29M	2.22%	$87.03M
Pfizer	505.64K	1.77%	$4.23M
5am venture management	738.97K	1.74%	$6.25M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	17.53M	0.07%	16.13M
Blackrock funding, inc. /de	11.22M	0.00%	1.77M
Cormorant asset management, lp	1.76M	0.75%	1.75M
Stempoint capital lp	1.59M	2.62%	1.59M
Vanguard group	4.40M	0.00%	1.52M

Top Sellers

Holder	Shares	% Assets	Change
Farallon capital management	-	-	-4.81M
Armistice capital	-	-	-2.14M
Schonfeld strategic advisors	-	-	-1.61M
Perceptive advisors	-	-	-1.49M
Darwin global management	-	-	-1.48M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	902.57K	0.00%	902.57K	$33.71M
Vanguard fiduciary trust	701.59K	0.00%	701.59K	$5.94M
Artal group	306.70K	0.27%	306.70K	$10.65M
Weiss asset management lp	242.12K	0.04%	242.12K	$3.63M
Renaissance	160.95K	0.00%	160.95K	$1.36M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Beacon capital management	-1.00
Allspring global investments	-2.00
Southstate	-3.00
Gps wealth strategies group	-5.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	130	-56.67%	27,427,931	-77.41%	22	0.17%	63	-67.19%	27	-51.79%
Dec 31, 2025	169	-43.48%	54,678,322	-35.28%	51	0.76%	99	-28.26%	37	-51.32%
Sep 30, 2025	286	10.00%	83,525,986	-0.78%	81	1.21%	132	-2.94%	74	10.45%
Jun 30, 2025	268	-3.60%	86,968,877	-2.99%	84	1.10%	138	-2.82%	70	-9.09%
Mar 31, 2025	20	-92.51%	4,003,493	-95.66%	3	0.04%	9	-94.12%	7	-89.23%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	4.24M	2.82%	-42.38K
Vanguard Total Stock Mkt Idx Inv	2.83M	2.68%	-62.83K
Vanguard US Total Market Shares ETF	2.43M	2.38%	217.08K
BB Biotech AG Ord	2.80M	2.11%	-
Vanguard Small Cap Index	2.11M	1.99%	-14.23K
iShares Russell 2000 ETF	2.77M	1.84%	23.36K
Janus Henderson Global Life Sciences D	2.22M	1.47%	171.38K
Janus Henderson Global Life Sciences	2.22M	1.47%	2.22M
SPDR® S&P Biotech ETF	1.48M	1.40%	3.29K
Janus Global Life Science AUSD	2.07M	1.38%	2.07M

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2025	CHILDS JOHN W	-	Buy	$864.12K
Nov 17, 2025	Clark George C.	VP, Chief Accounting Officer	Buy	$144.77K
Nov 13, 2025	Bailey Gregory	-	Buy	$3.00M
Nov 13, 2025	CHILDS JOHN W	-	Buy	$25.00M
Nov 13, 2025	Coric Vlad	Chief Executive Officer	Buy	$2.50M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	5	-
2025 Q2	-	-
2025 Q1	4	-

BHVN Ownership FAQ

Who Owns Biohaven?

Biohaven shareholders are primarily institutional investors at 22.82%, followed by 11.08% insiders and 66.10% retail investors. The average institutional ownership in Biohaven's industry, Biotech Stocks , is 35.75%, which Biohaven falls below.

Who owns the most shares of Biohaven?

Biohaven’s largest shareholders are Janus henderson group (17.53M shares, 14.59%), Blackrock funding, inc. /de (11.22M shares, 9.34%), and Suvretta capital management (10.29M shares, 8.56%). Together, they hold 32.49% of Biohaven’s total shares outstanding.

Does Blackrock own Biohaven?

Yes, BlackRock owns 7.56% of Biohaven, totaling 6.17M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 214.15M$. In the last quarter, BlackRock increased its holdings by 446.83K shares, a 7.81% change.

Who is Biohaven’s biggest shareholder by percentage of total assets invested?

Rp management is Biohaven’s biggest shareholder by percentage of total assets invested, with 64.43% of its assets in 2.94M Biohaven shares, valued at 146.74M$.

Who is the top mutual fund holder of Biohaven shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Biohaven shares, with 2.82% of its total shares outstanding invested in 4.24M Biohaven shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools